has been cited by the following article(s):
|
[1]
|
A review on the medicinal chemistry of sodium glucose co-transporter 2 inhibitors (SGLT2-I): Update from 2010 to present
European Journal of Medicinal Chemistry Reports,
2022
DOI:10.1016/j.ejmcr.2022.100074
|
|
|
|
|
[2]
|
A review on the medicinal chemistry of sodium glucose co-transporter 2 inhibitors (SGLT2-I): Update from 2010 to present
European Journal of Medicinal Chemistry Reports,
2022
DOI:10.1016/j.ejmcr.2022.100074
|
|
|
|
|
[3]
|
A review on the medicinal chemistry of sodium glucose co-transporter 2 inhibitors (SGLT2-I): Update from 2010 to present
European Journal of Medicinal Chemistry Reports,
2022
DOI:10.1016/j.ejmcr.2022.100074
|
|
|
|
|
[4]
|
A review on the medicinal chemistry of sodium glucose co-transporter 2 inhibitors (SGLT2-I): Update from 2010 to present
European Journal of Medicinal Chemistry Reports,
2022
DOI:10.1016/j.ejmcr.2022.100074
|
|
|
|
|
[5]
|
Integrated computational approach on sodium-glucose co-transporter 2 (SGLT2) Inhibitors for the development of novel antidiabetic agents
Journal of Molecular Structure,
2021
DOI:10.1016/j.molstruc.2020.129511
|
|
|
|
|
[6]
|
Integrated computational approach on sodium-glucose co-transporter 2 (SGLT2) Inhibitors for the development of novel antidiabetic agents
Journal of Molecular Structure,
2021
DOI:10.1016/j.molstruc.2020.129511
|
|
|
|
|
[7]
|
Comprehensive structure–activity relationship (SAR) investigation of C-aryl glycoside derivatives for the development of SGLT1/SGLT2 dual inhibitors
New Journal of Chemistry,
2021
DOI:10.1039/D1NJ02510D
|
|
|
|
|
[8]
|
Cheonggukjang-Specific Component 1,3-Diphenyl-2-Propanone as a Novel PPARα/γ Dual Agonist: An In Vitro and In Silico Study
International Journal of Molecular Sciences,
2021
DOI:10.3390/ijms221910884
|
|
|
|